HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs - 1 - Full Text View

Purpose

The purpose of this study is to evaluate a five-session Human Immunodeficiency Virus/Acquired Immune Deficiency Disease (HIV/AIDS) group therapy designed specifically for heterosexual men. This therapy is compared to standard HIV/AIDS education, which generally consists of a single session of HIV education.

Condition	Intervention	Phase
Behavior Therapy	Behavioral: Behavior Therapy	Phase III

MedlinePlus related topics:

AIDS

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment

Official Title:	HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

AIDS risk behavior

Estimated Enrollment:	630
Study Start Date:	April 2004
Study Completion Date:	September 2005
Primary Completion Date:	September 2005 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

All adult males age 18 and above in drug abuse treatment at participating Community Treatment Providers will be invited to participate.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00084175

Locations


United States, California
	Matrix Institute on Addictions
	Rancho Cucamonga, California, United States, 91730
	San Francisco General Hospital
	San Francisco, California, United States, 94110

United States, Connecticut
	CT Renaissance, Inc.
	Norwalk, Connecticut, United States, 06852
	Hartford Dispensary
	New Britain, Connecticut, United States, 06051

United States, New Mexico
	Life Link
	Santa Fe, New Mexico, United States, 87505

United States, New York
	Staten Island University Hospital
	Staten Island, New York, United States, 10309

United States, North Carolina
	South Light
	Raleigh, North Carolina, United States, 27604
	Addiction Drug Services-Highpoint
	High Point, North Carolina, United States, 27265

United States, Ohio
	Comprehensive Addiction Services System
	Toledo, Ohio, United States, 43620

United States, Pennsylvania
	The Consortium
	Philadelphia, Pennsylvania, United States, 19104
	Thomas Jefferson Intensive Sub. Abuse TP
	Philadelphia, Pennsylvania, United States, 19107

United States, South Carolina
	LRADAC-Lexington-Richmond Alcohol & Drug Council
	Columbia, South Carolina, United States, 29204

United States, Washington
	Evergreen Treatment Services
	Seattle, Washington, United States, 98134 1618

United States, West Virginia
	Prestera Center for Mental Health Svcs.
	Huntington, West Virginia, United States, 25704

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

University of Washington

Investigators


Principal Investigator:	Donald Calsyn, Ph.D.	University of Washington

More Information

Study ID Numbers:	NIDA-CTN-0018-1
First Received:	June 8, 2004
Last Updated:	July 28, 2008
ClinicalTrials.gov Identifier:	NCT00084175
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

HIV Infections

Acquired Immunodeficiency Syndrome

ClinicalTrials.gov processed this record on September 05, 2008

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) University of Washington
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00084175